Blueprint Medicines Investor Relations Material
Latest events
Q1 2025
Blueprint Medicines
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Blueprint Medicines Corp
Access all reports
Blueprint Medicines Corp. is a biopharmaceutical company focused on developing targeted therapies for genomically defined cancers and rare diseases. The company utilizes precision medicine approaches to design small-molecule drugs that inhibit specific genetic drivers of disease. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Blueprint Medicines Corp
Q4 2024
Blueprint Medicines Corp
Q4 2024
Blueprint Medicines Corp
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BPMC
Country
🇺🇸 United States